Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

U.S. launch for Aptivus

July 6, 2005

Agents for HIV infection in early development

July 4, 2005

Novel integrase inhibitors with different pharmacophores discovered

July 4, 2005

BILR-355-BS shows potent antiviral activity against majority of NNRTI-resistant isolates

July 1, 2005

454's ultra-deep sequencing able to detect low levels of drug-resistant HIV

June 30, 2005

Novel agents for AIDS imparted by ViroChem

June 27, 2005

BI-201 begins phase I/IIa studies for HIV

June 27, 2005

Enrollment open in phase I/II study of HIV integrase inhibitor GS-9137

June 27, 2005

Accelerated approval for Aptivus in HIV

June 23, 2005

GSK Biologicals and IAVI to develop AIDS vaccine

June 23, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...